In use product safety assessment report for the Pevanti® (prednisolone tablet) range

A UKMi Product Safety assessment for the Pevanti® (prednisolone tablet) range which describes the in-use medication safety considerations resultant from the product’s presentation or other pre-defined characteristics. Potential next steps and mitigation actions are suggested. UKMi Product Safety assessments are produced using the validated UKMi product assessment tool which can be found below.


The UKMI product safety assessment group would appreciate your views on the usefulness of this assessment. We have devised a short survey which we would appreciate you completing, it should take approximately 10 minutes to complete. Click here –  – to complete the survey.